Limitations, agreements, and source contact

Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck · Source last updated 2024-08-22

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

true

limitations And Caveats

description

Outcomes data from 6 participants who received the same treatment on CWRU1301 (NCT00049283) were including in the results for this record.

point Of Contact

email

CTUReferral@UHhospitals.org

organization

University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center

phone

1-800-641-2422

title

Dr. Min Yao, MD

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice